Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07180147 · ClinicalTrials.gov registry record

Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)

A clinical trial of Hypertension and Healthy Aging, sponsored by Marymount University.

Active
Registry status
500
Enrollment target
1
Study location

NCT07180147 is a study of Hypertension and Healthy Aging that is active but no longer recruiting, run by Marymount University. The registered enrollment target is 500 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07180147, a study of Hypertension and Healthy Aging, is active but no longer recruiting, sponsored by Marymount University.

ACTIVE NOT RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

The Arlington Longitudinal Optimal Healthy Aging (ALOHA) Study is a community-based research project led by the Marymount University Center for Optimal Aging (MCOA). The study is designed to help older adults in the Washington, D.C., Maryland, and Virginia (DMV) area maintain independence, mobility, wellbeing and brain health as they age. Adults aged 50 years and older will receive a comprehensive health assessment at the study site, Center for Optimal Aging- ALOHA Lab at Marymount University (MU) Ballston Campus in Arlington, Virginia. The assessment includes physical and cognitive testing, health and medical history, lifestyle surveys, and biometric measures such as blood pressure, grip strength, body composition by the InBody system, balance and gait speed. Participants will receive their results in a personalized "Health Passport," which summarizes findings and provides tailored recommendations to help manage modifiable health risk factors-such as those linked to Alzheimer's disease, cardiovascular disease, frailty syndrome, and depression. Participants will return annually for up to 5 years to repeat assessments and receive updated health and wellness recommendations. The study will track changes in health over time and explore the impact of the Health Passport on health behaviors, functional independence, and quality of life. ALOHA will also evaluate the cultural appropriateness of the Health Passport for diverse populations in Northern Virginia. The program incorporates an interprofessional research model, engaging researchers from multiple health professions to work alongside older adults, supporting both participants' wellness and optimal aging.

Study Locations (1)

Virginia

  • Center for Optimal Aging, Marymount University - Arlington

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2025-05-01
Est. Completion 2031-07-30

Sponsor

Marymount University

6 total trials

What the Registry Record Tells You About NCT07180147

The ClinicalTrials.gov registry entry for NCT07180147 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (86% lower). The listed sponsor is Marymount University, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 9 conditions, with Hypertension appearing as the primary indexed condition, and to 0 interventions.

NCT07180147 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT07180147 about?

NCT07180147 is a clinical study titled "Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)". The Arlington Longitudinal Optimal Healthy Aging (ALOHA) Study is a community-based research project led by the Marymount University Center for Optimal Aging (MCOA). The study is designed to help older adults in the Washington, D.C., Maryland, and Virginia (DMV) area maintain independence, mobility,...

What is the current status of trial NCT07180147?

This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2025-05-01. Estimated completion is 2031-07-30.

What conditions does trial NCT07180147 study?

This clinical trial studies the following conditions: Hypertension, Healthy Aging, Mild Cognitive Impairment (MCI), Disability Physical, Obesity &Amp; Overweight.

Who is sponsoring clinical trial NCT07180147?

This trial is sponsored by Marymount University, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07180147 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.